scispace - formally typeset
I

Ivana De Domenico

Researcher at University of Utah

Publications -  49
Citations -  5512

Ivana De Domenico is an academic researcher from University of Utah. The author has contributed to research in topics: Ferroportin & Hepcidin. The author has an hindex of 30, co-authored 49 publications receiving 5158 citations. Previous affiliations of Ivana De Domenico include University of Messina.

Papers
More filters
Journal ArticleDOI

The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin.

TL;DR: The inhibitory effect of matriptase-2 on hepcidin promoter is confirmed and it is shown that matript enzyme-2 lacking the serine protease domain is fully inactive and that mutant R774C found in patients with genetic iron deficiency has decreased inhibitory activity.
Journal ArticleDOI

Regulation of iron acquisition and storage: consequences for iron-linked disorders

TL;DR: Findings of iron transporters and insights into their regulation have provided important information about iron metabolism and genetic iron disorders.
Journal ArticleDOI

The molecular mechanism of hepcidin-mediated ferroportin down-regulation

TL;DR: Ferroportin (Fpn) is the only known iron exporter in vertebrates and it is shown that after binding of hepcidin, Fpn is tyrosine phosphorylated at the plasma membrane, and adjacent tyrosines as the phosphorylation sites are identified.
Journal ArticleDOI

A heme export protein is required for red blood cell differentiation and iron homeostasis

TL;DR: In this paper, the feline leukemia virus, subgroup C, receptor (FLVCR) exports cytoplasmic heme to macrophages that ingest senescent red cells and regulates hepatic iron.
Journal ArticleDOI

Ferroxidase activity is required for the stability of cell surface ferroportin in cells expressing GPI‐ceruloplasmin

TL;DR: The requirement for a ferroxidase to maintain iron transport activity represents a new mechanism of regulating cellular iron export, a new function for Cp and an explanation for brain iron overload in patients with aceruloplasminemia.